Hispanics have the lowest stem cell transplant utilization rate for autologous hematopoietic cell transplantation for multiple myeloma in the United States: A CIBMTR report
Abstract
Race/ethnicity remains an important barrier in clinical care. The authors investigated differences in the receipt of autologous hematopoietic cell transplantation (AHCT) among patients with multiple myeloma (MM) and outcomes based on race/ethnicity in the United States.
Document Details
- Document Type
- Pub Defense Publication
- Publication Date
- May 04, 2017
- Source ID
- 10.1002/cncr.30747
Entities
People
- Anita D'Souza
- Attaphol Pawarode
- Baldeep Wirk
- David H. Vesole
- David I. Marks
- Jeffrey R. Schriber
- Kwang Woo Ahn
- Luciano J. Costa
- Miguel Angel‐diaz
- Mingwei Fei
- Mohamad A. Kharfan‐dabaja
- Parameswaran N. Hari
- Peter H. Wiernik
- Richard F. Olsson
- Robert P. Gale
- Saad Z. Usmani
- Saulius K. Girnius
- Shahrukh K Hashmi
- Siddharatha Ganguly
- Taiga Nishihori
- Tomer M. Mark
- Yago L. Nieto
Organizations
- H. Lee Moffitt Cancer Center & Research Institute
- Health Resources and Services Administration
- Imperial College London
- Karolinska Institutet
- Levine Cancer Institute
- Mayo Clinic
- Medical College of Wisconsin
- National Cancer Institute
- National Center for Advancing Translational Sciences
- National Heart, Lung, and Blood Institute
- National Institute of Allergy and Infectious Diseases
- National Institutes of Health
- Office of Naval Research
- Seattle Cancer Care Alliance
- University of Alabama at Birmingham
- University of Cincinnati
- University of Kansas
- University of Michigan
- University of Texas at Austin
- Uppsala University
- Weill Cornell Medicine